BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1969348)

  • 1. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients.
    Nauck M; Stöckmann F; Creutzfeldt W
    Eur J Clin Invest; 1990 Feb; 20(1):15-28. PubMed ID: 1969348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.
    Nauck MA; Meier JJ
    Ann Intern Med; 2012 Dec; 157(11):767-75. PubMed ID: 23208166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma.
    Nauck MA; Baum F; Seidensticker F; Røder M; Dinesen B; Creutzfeldt W
    Eur J Clin Invest; 1997 Feb; 27(2):109-15. PubMed ID: 9061303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of endogenous insulin secretion by exogenous insulin in patients with insulinoma.
    Kim CH; Park JY; Shong YK; Hong SK; Kim GS; Lee KU
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):87-92. PubMed ID: 10651758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified hyperinsulinaemic, eu- and hypoglycaemic clamp technique using lispro-insulin for insulinoma diagnostic.
    Roudovitch N; Nauck MA; Schatz H; Pfeiffer AF
    Exp Clin Endocrinol Diabetes; 2001; 109(8):397-401. PubMed ID: 11748487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypoglycemic and hyperinsulinemic clamp technic to determine the secretory behavior of insulinoma].
    Hütter R; Irsigler K; Vesely M; Ogris E
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1146-8. PubMed ID: 2839328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anomalous glucose and insulin responses in patients with insulinoma. Caveats for diagnosis.
    Dons RF; Hodge J; Ginsberg BH; Brennan MF; Cryer PE; Kourides IA; Gorden P
    Arch Intern Med; 1985 Oct; 145(10):1861-3. PubMed ID: 2994586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to suppress C-peptide secretion by euglycaemic hyperinsulinaemia: a new diagnostic test for insulinoma?
    Yki-Järvinen H; Pelkonen R; Koivisto VA
    Clin Endocrinol (Oxf); 1985 Oct; 23(4):461-6. PubMed ID: 2998651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazoxide infusion test in patients with single benign insulinoma.
    Tamburrano G; Lala A; Mauceri M; Leonetti F; Libianchi S; Andreani D
    Horm Res; 1983; 17(3):141-6. PubMed ID: 6303933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of suppression of insulin secretion by hyperinsulinemia in a patient with an insulinoma.
    Cohen P; Barzilai N; Bar-Ilan R; Yassin K; Karnieli E
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1411-3. PubMed ID: 3023422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin surrogates in insulinoma.
    O'Brien T; O'Brien PC; Service FJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):448-51. PubMed ID: 8345050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy in the diagnosis of insulinoma.
    Faber OK; Kehlet H
    Scand J Gastroenterol Suppl; 1979; 53():45-8. PubMed ID: 225787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.
    Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J
    Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma.
    Koivisto VA; Yki-Järvinen H; Hartling SG; Pelkonen R
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1117-20. PubMed ID: 3020076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic interpretation of the intravenous tolbutamide test for insulinoma.
    McMahon MM; O'Brien PC; Service FJ
    Mayo Clin Proc; 1989 Dec; 64(12):1481-8. PubMed ID: 2557494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-producing islet cell tumors.
    Fajans SS; Vinik AI
    Endocrinol Metab Clin North Am; 1989 Mar; 18(1):45-74. PubMed ID: 2537193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late post-prandial hypoglycaemia as the sole presenting feature of secreting pancreatic beta-cell adenoma in a subtotally gastrectomized patient.
    Del Sindaco P; Casucci G; Pampanelli S; Polonsky K; Fanelli C; Torlone E; Santeusanio F; Brunetti P; Bolli GB
    Eur J Endocrinol; 1997 Jan; 136(1):96-9. PubMed ID: 9037134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperinsulinic euglycemic clamp. Another approach to the diagnosis of insulinoma].
    Gin H; Brottier E; Ducorps M; Cuisinier-Raynal JC; Aubertin J
    Presse Med; 1985 Oct; 14(34):1799. PubMed ID: 2999757
    [No Abstract]   [Full Text] [Related]  

  • 19. Using the Secretion Ratios of Insulin and C-peptide During the 2-h Oral Glucose Tolerance Test to Diagnose Insulinoma.
    Liao J; Ding F; Luo W; Nie X; He Y; Li G
    Dig Dis Sci; 2021 May; 66(5):1533-1539. PubMed ID: 32529519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide during the prolonged fast in insulinoma.
    Service FJ; O'Brien PC; McMahon MM; Kao PC
    J Clin Endocrinol Metab; 1993 Mar; 76(3):655-9. PubMed ID: 8445021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.